Tech Company Financing Transactions
NRG Therapeutics Funding Round
On 9/8/2025, NRG Therapeutics raised $68 million in Series B funding from Dementia Discovery Fund, Brandon Capital Partners and British Business Bank.
Transaction Overview
Company Name
Announced On
9/8/2025
Transaction Type
Venture Equity
Amount
$68,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to enable NRG Therapeutics to deliver clinical proof of concept in ALS/MND with NRG5051, a first-in-class, oral inhibitor of the mitochondrial permeability transition pore (mPTP)The mPTP is a well-established driver of mitochondrial dysfunction, inflammation, and neuronal death in neurodegenerative diseases.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Stevenage Bioscience Catalyst Gunnels Wood Road
Stevenage Herts, SG1 2FX
UK
Stevenage Herts, SG1 2FX
UK
Phone
Undisclosed
Website
Email Address
Overview
NRG Therapeutics is passionate about bringing new medicines and hope to the growing number of people worldwide living with debilitating neurodegenerative disorders. A neuroscience-focussed drug discovery company building a pipeline of disease modifying drug candidates, NRG Therapeutics is focused on therapeutic approaches that will restore mitochondrial function and slow or halt the progression of neurodegenerative diseases such as Parkinson's and Amyotrophic Lateral Sclerosis, ALS (also known as motor neurone disease, MND).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Neil Miller
Chief Operating Officer
Grant Hawthorne
Co-Founder
Anthony Rutter
Browse more venture capital transactions:
Prev: 9/8/2025: Kin Insurance venture capital transaction
Next: 9/9/2025: Higgsfield AI venture capital transaction
Share this article
News on VC Transactions
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs